Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Moolec Science S.A. is an innovative biotechnology firm specializing in the development of plant-grown animal proteins. Leveraging a transformative method called Molecular Farming, the company is poised to disrupt the alternative protein market. Their product lines and research and development efforts capitalize on the inherent agricultural benefits of select host crops, such as soybeans and peas. Globally, Moolec maintains operations across the United States, Europe, and South America. Established in 2008, the company is headquartered in Luxembourg.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Target Price
The average target price of MLEC is 3.0 and suggests 61% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decr